Characterization of novel oral splicing modulator, H3B-8800, identifies the mechanistic basis for its preferential lethality towards spliceosome-mutant myeloid malignancy models Meeting Abstract


Authors: Buonamici, S.; Yoshimi, A.; Thomas, M.; Seiler, M.; Chan, B.; Csibi, A.; Fekkes, P.; Klimek, V.; Kumar, P.; Lee, S. C. W.; Padron, E.; Pazolli, E.; Goldberg, J.; Sahmoud, T.; Taylor, J.; Warmuth, M.; Yu, L.; Zhu, P.; Abdel-Wahab, O.; Smith, P.
Abstract Title: Characterization of novel oral splicing modulator, H3B-8800, identifies the mechanistic basis for its preferential lethality towards spliceosome-mutant myeloid malignancy models
Meeting Title: 14th International Symposium on Myelodysplastic Syndromes (MDS)
Journal Title: Leukemia Research
Volume: 55
Issue: Suppl. 1
Meeting Dates: 2017 May 3-6
Meeting Location: Valencia, Spain
ISSN: 0145-2126
Publisher: Elsevier Ltd  
Date Published: 2017-04-01
Start Page: S11
Language: English
ACCESSION: WOS:000417653300021
PROVIDER: wos
DOI: 10.1016/S0145-2126(17)30133-9
Notes: Meeting Abstract: 20 -- 14th International Symposium on Myelodysplastic Syndromes (MDS) -- MAY 03-06, 2017 -- Valencia, SPAIN -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Virginia Klimek
    147 Klimek
  2. Stanley Chun-Wei Lee
    43 Lee
  3. Akihide   Yoshimi
    35 Yoshimi
  4. Justin   Taylor
    51 Taylor